PHILADELPHIA, Pa., Jan. 8, 2016 (GLOBE NEWSWIRE) -- Independence Health Group today announced that members of its leadership team will present at the 34th annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 11, 2016.
Daniel J. Hilferty, Independence Health Group president and chief executive officer, and Paul A. Tufano, Independence Health Group executive vice president and AmeriHealth Caritas chairman and chief executive officer, are scheduled to present at the conference at 2:30 p.m. PST.
About Independence Health Group
Independence Health Group, together with its subsidiaries, serves nearly 10 million people in 34 states and the District of Columbia, including 2.5 million in southeastern Pennsylvania. In addition to a growing consumer business, Independence serves more than 31,000 employer groups ranging from small businesses to national corporations. Headquartered in Philadelphia, Independence is a diversified company offering a wide range of services including commercial, Medicare and Medicaid medical coverage, third-party benefits administration, pharmacy benefits management, and workers' compensation. Independence Health Group is an independent licensee of the Blue Cross and Blue Shield Association.
CONTACT: Nadina Fraimow Bronstein
215-241-4645
[email protected]


TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Britain Courts Anthropic Amid US Defense Department Dispute
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO 



